RxDoctor Payments DataLook up a doctor →

Melissa Jones

Neurology with Special Qualifications in Child Neurology · Katy, TXNPI 1114170123

Payments from drug & device makers

$9,744in general payments, 2019–2025

Across 476 payments — averaging $20.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UCB, Inc.$1K
  • Supernus Pharmaceuticals, Inc.$1K
  • W. L. Gore & Associates, Inc.$725
  • Jazz Pharmaceuticals Inc.$706
  • Ironshore Pharmaceuticals Inc.$584
  • Neurelis, Inc.$508
  • plus $5K from 50 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
UCB, Inc.60$1,196
Supernus Pharmaceuticals, Inc.85$1,147
W. L. Gore & Associates, Inc.7$725
Jazz Pharmaceuticals Inc.38$706
Ironshore Pharmaceuticals Inc.39$584
Neurelis, Inc.17$508
Corium, LLC22$442
Eisai Inc.19$417
Neos Therapeutics, LP29$366
Tris Pharma Inc20$363
Sunovion Pharmaceuticals Inc.3$351
Greenwich Biosciences, Inc.20$339
Aquestive Therapeutics, Inc.13$251
Harmony Biosciences LLC9$228
SK Life Science, Inc.11$226
Sumitomo Pharma America, Inc.11$209
Avadel CNS Pharmaceuticals, LLC6$159
E.r. Squibb & Sons, L.L.C.1$119
Livanova USA, Inc.4$115
AbbVie(2 entities)5$106
Arbor Pharmaceuticals, Inc.6$102
Acadia Pharmaceuticals Inc4$93
Octapharma USA, Inc.2$84
Takeda Pharmaceuticals U.S.A., Inc.3$81
Biohaven Pharmaceutical Holding Company Ltd.4$75
Shire North American Group Inc3$49
Aprecia Pharmaceuticals, LLC1$47
Biogen2$41
Catalyst Pharmaceuticals, Inc.2$41
Biohaven Pharmaceuticals, Inc.2$41
Zogenix Inc.2$34
PTC Therapeutics, Inc.1$32
Johnson & Johnson1$31
Rhodes Pharmaceuticals L.p.2$30
Otter Pharmaceuticals, LLC1$29
Immedica Pharma US, Inc.1$28
Vertical Pharmaceuticals, LLC1$26
Axsome Therapeutics, Inc.1$26
Hospira, Inc.1$25
Mallinckrodt Enterprises LLC1$25
Collegium Pharmaceutical, Inc.1$23
Novartis1$23
Pfizer1$22
Teva Pharmaceuticals USA, Inc.1$17
Noven Therapeutics, LLC1$17
Assertio Therapeutics, Inc.1$16
Ultragenyx Pharmaceutical Inc.1$15
OWP Pharmaceuticals, Inc.1$14
Upsher-smith Laboratories LLC1$14
Adlon Therapeutics L.p.1$14
Cranial Technologies, Inc1$14
Promius Pharma LLC1$14
Sanofi1$13
Aucta Pharmaceuticals, Inc.1$12
Biomarin Pharmaceutical Inc.1$11
Travere Therapeutics, Inc.1$10

How this compares

$9,744 in reported general payments places this provider in the 70th percentile of 193 neurology with special qualifications in child neurology providers in Texas.

See all neurology with special qualifications in child neurology providers in Texas →

Other neurology with special qualifications in child neurology in Katy

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →